Clarivate™ is a leading global provider of transformative intelligence. Learn more about our mission and what we do
Executive Leadership
Our global leadership is committed to accelerating the pace of innovation.Learn more about our leaders
Sustainability
Sustainability is a core component of our goals. Learn more about our approach
Featured articles
Sustainability – The foundation of everything we do
At Clarivate, we have created an interconnected, shared purpose that guides every decision we make in order to improve environmental, social, and governance issues worldwide.
How Clarivate uses Artificial Intelligence you can trust to transform your world
Our dedicated Data Science team have implemented AI across our portfolio to enhance our tools and solutions for decades, and they are forward thinking in their approach to utilizing new technology as it emerges.
News and insights from Clarivate.Read the latest news
Featured news
Clarivate Expands Partnership with VeriSIM Life to Accelerate and De-risk Research and Drug Development
Clarivate announced the launch of VeriSIM Life Translational Index™ on Cortellis Drug Discovery Intelligence by Clarivate. The integrated workflow provides customers with a diverse array of predictive compound safety and efficacy insights.
Clarivate and the Chinese Academy of Sciences Release Annual Report to Identify 128 Research Fronts
Clarivate and the Chinese Academy of Sciences released their “Research Fronts 2023” annual joint report which identified a total of 128 Research Fronts including 110 “hot” and 18 “emerging” Fronts.
We believe that the best results come from working together in respectful partnership with our colleagues and customers.See how we keep our customers first
Clarivate Reveals World’s Influential Researchers in Highly Cited Researchers 2023 List
Clarivate revealed its 2023 list of Highly Cited Researchers™ – influential researchers at universities, research institutes and commercial organizations around the world who have demonstrated significant and broad influence in their fields of research.
Trusted partner to innovators everywhere. Learn more about how we help our customers
Featured stories
Case study: Understanding competitive dynamics at IQGEN-X
India-based IQGEN-X turned to Cortellis Generics Intelligence to aid in its strategic planning and improve ROI.
Enabling research excellence in the health sciences
Acibadem University, Türkiye uses citation analytics to elevate its performance and establish itself as an expert in health sciences globally
Whether you’re looking for product support, learning and training or have billing or invoice inquiries, we can help.Get help
Academia & Government
Drive research excellence and student success. Learn more
Deliver innovative, impactful research outcomes by equipping your institution with trustworthy, curated data, flexible solutions, and unbiased expertise. Learn more.
Research discovery and referencing
Research funding and analytics
Publisher solutions
Industry insights
The Institute for Scientific Information
Fostering the scientometric community through research and collaboration.
Research Professional News
A trusted source for authoritative, editorially independent news and analysis.
Content solutions delivered in context to help researchers, faculty and students achieve success in research and learning. Learn more.
Menu Item
Featured products
ProQuest One Academic
Meet the needs of students and faculty with a collection of essential multiformat content, all in one place.
ProQuest Historical Newspapers
Access sought-after primary sources with the definitive digitized newspaper archive with over 50 million pages.
ProQuest Dissertations & Theses Global
Uncover new ideas and research innovations in the world’s most comprehensive curated collection of multidisciplinary dissertations and theses.
Unparalleled content aggregation and curation and marketplaces for content discovery, acquisition and insights. Learn more.
Academic Complete
This affordable subscription comes with a growing selection of 234,000+ titles that support curricula, graduation rate trends and emerging courses
Ebooks Offers
Make the most of your library collection budget and explore offers from key academic publishers and university presses
Curated Topics
Expertly selected title lists, created by and for librarians, that feature the latest and most-requested front-list electronic and print books
Revolutionizing library technology through connection, collaboration, and innovation. Learn more.
Public Libraries
Academic Libraries
Alma
Manage print, electronic, and digital materials in a single interface using the leading unified library services platform.
Primo
Maximize the exposure of your library collections, and provide students and researchers with fast access to scholarly materials.
Achieve important national outcomes with the world’s most trusted data and intelligence. Learn more.
Pivot-RP
Increase funding success rates using an expert-curated source of global funding opportunities with powerful workflow, intelligence and discovery tools.
Life Sciences & Healthcare
Advance innovation and accelerate patient outcomes. Learn more
Gain patient insights today for a healthier tomorrow. Learn more.
Areas of expertise
Clarivate Patient Data Intelligence
Self-service platform that provides instantaneous insight into patient care, dispensing, and prescribing trends.
Healthbase
The industry’s most accurate and intelligent affiliations platform.
Integrated Patient Journey
Drive better outcomes with multi-layered insights and analytics.
Plan innovative solutions and drive portfolio value. Learn more.
Market Assessment
Competitive Intelligence
Partner Identification and Deal-making
Featured resources
What a string of semaglutide biosimilars could mean for Mainland China
The Mainland China market for GLP-1 drugs to treat obesity and diabetes is valued at approximately $1.7 billion.
Where pharma is investing for the future of medicine
Amid great economic uncertainty and following a tremendous drop in biotech valuations, the atmosphere for dealmaking in the biopharma sector remains unsettled.
Disease epidemiology: leveraging diverse data for innovation
Epidemiological intelligence helps life science companies understand the disease landscape and size global markets, enabling them to identify growth opportunities and more.
Optimize drug discovery, successfully translate drugs from lab to clinic, and ensure regulatory approval driven by transformative intelligence across the R&D life cycle. Learn more
Discovery & Development
Regulatory & Compliance
Pharmacovigilance & Drug Safety
Benchmarking and R&D Consulting Services
For over 25 years, CMR has worked with the leading global biopharmaceutical companies to assess R&D and Clinical productivity and provide actionable data and insights.
Optimizing clinical trials using real-world data
This report examines how drug developers are using real-world data to shape, supplement, and accelerate their clinical trials.
Drugs to Watch 2024
From CRISPR to bispecifics, cancer to COPD, new drugs on the cusp
Strategically launch and position your product in the market for maximum patient benefit. Learn more
Products & Services
Fingertip Formulary™ Suite
Maximize market access opportunities with formulary data and interactive tools to track your brands versus competitors.
Patient Connect
Enabling life science companies to identify and support patients at the point of care and point of dispensing.
Real-World Data
Dive deep into the provider, patient, payer relationships to understand the complexity of care and treatment and get granular information on the patient healthcare experience, utilization patterns and direct cost expenditures.
Solutions that transform complex market, API, and regulatory data into actionable insights, driving efficient supply chain management and strategic manufacturing decision-making. Learn more
Global Q Inc. is now part of Clarivate. Learn more.
Cortellis CMC Intelligence
Simplify access to regional governance and reduce research time with a single source of global chemistry, manufacturing and controls (CMC) requirements.
Cortellis Generics Intelligence
Make timely and data-driven business decisions in the biopharma generics and biosimilars markets with a single source of market performance, patent and manufacturing data.
Our integrated research and data, analytics and consulting solutions enable clients to make better, more informed decisions in a rapidly changing landscape. Learn more.
Life Sciences and Healthcare experts
Our 300-strong consulting team includes therapy area specialists, data scientists, industry experts and analysts.
Make your commercialization planning easier and more effective with medtech innovation. Learn more.
Medtech360
Make informed, strategic decisions and respond to an evolving market through medtech insights.
Medical Supply Distribution
Comprehensive medical supply market share intelligence and actionable insights to track real-time trends
Procedure Finder
Understand where patients are receiving procedures to improve device marketing strategy and patient experience.
Plan your portfolio and get affordable treatments to patients. Learn more.
Cortellis Competitive Intelligence
Monitor the competitive landscape, validate investments and strategically prioritize your portfolio so you can focus on maximizing ROI and improving patient outcomes.
Cortellis Drug Discovery Intelligence
Accelerate development with complete preclinical drug intelligence.
Intellectual Property
Transform the way you create, manage and protect intellectual property. Learn more
Software that simplifies the process of managing intellectual property assets. Learn more
For Corporates
For Law Firms
Productivity Solutions
IPfolio
Leading IP management software for corporations.
FoundationIP
Leading IP management software for law firms.
IP Management Consulting
Transform your operations and unveil the maximum potential of your IP.
Expert administrative support to optimize patent workflows. Learn more.
Patent Maintenance
Patent Administrative Services
Docketing
Get reliable, world-class support on your prosecution correspondence.
Unitary Patent Support
Expert services to help you navigate the European Unitary Patent.
Patent data, software and expert research for insights you can trust. Learn more.
Patent Search & Watch
Patent Analytics
Patent Data Feeds & APIs
Derwent Innovation
Trusted patent search software for high confidence decisions.
Innography
Patent intelligence software that delivers IP answers for business results.
Patent Search Services
Expert patent research for more confident patentability, FTO and in(validity) decisions.
Trademark solutions to build, protect and expand strong brands. Learn more.
Trademark Search
Trademark Watch
Trademark Managed Services
Trademark Data & APIs
Clarivate Brand Landscape Analyzer
AI-enhanced research tool for assessing legal and commercial risk for new brands
Trademark Analytics
Delivers custom trademark analytics in a curated, interactive and highly readable format.
Darts-ip
IP intelligence for comprehensive insights into the litigation landscape of any IP asset
Global IP case law that informs confident IP decisions. Learn more.
Litigation & Opposition Intelligence
Litigation Research Services
Litigation Data & APIs
Darts-ip Patent Case Law Data
The leading source of global patent case data, litigation trends and insights.
Darts-ip Trademark Case Law Data
The largest and only global IP case law database dedicated to trademark cases.
Case Law Search Services
Empower strategic IP decisions from our experts at Clarivate Center for IP Innovation and Research through tailored guidance. Learn more.
Intelligence Consulting
Featured research
Top 100 Global Innovators – 2024
Resources
Keep up with the latest news, insights and research from Clarivate. Read our blog
Change on the horizon: The evolving IP legal profession
By the year 2030, it is likely the legal space will look and operate differently to today, reshaping the way IP professionals work. What could this mean for the future of the IP legal profession?
Best practices for AI and ML use across the drug discovery and development lifecycle
The speed of drug discovery and development are being transformed by AI and machine learning applications. AI and life science companies need to conduct due diligence to ensure optimal results and avoid the pitfalls of AI capabilities.
Researchers of Nobel class: Citation Laureates 2023
The Citation Laureates™ 2023 list has been announced, recognizing a select group of influential, highly cited researchers whose contributions are on par with Nobel Prize recipients.
Novel solutions derived from our unique capabilities and those of our carefully selected partners. Learn more
Featured apps
IP-GeoScape®
From our solution partner, Accencio® – a visual landscape of the molecular IP space that reveals the multi-dimensional relationship between molecules within a target area of interest.
ClaRITA – Clarivate Regulatory Intelligence Tracking App
Provide your pharmacovigilance, safety, clinical, and technical operations teams the information they need to monitor changing legislation and regulations.
Partners
Partner with us and help accelerate innovation.
World-changing research should be seen, shared and celebrated. Learn more
Featured programs
Highly Cited Researchers
Researchers who have demonstrated significant and broad influence reflected in their publication of multiple highly cited papers over the last decade.
Citation Laureates
Researchers whose work is deemed to be of Nobel stature, as attested by markedly high citation tallies recorded in the Web of Science.
Eugene Garfield Award
This award honors Eugene Garfield’s legacy and recognizes early career researchers in scientometrics developing innovative techniques in citation analysis.
Webinars
Live and on-demand webinars from our experts.
Featured webinars
Let’s get real about data and AI
How real world data, real world evidence and AI/machine learning are poised to transform biopharma innovation and delivery of care.
Building a stronger patent portfolio: Strategies for data-driven patent portfolio management
Clarivate experts share key strategies from working with some of the world’s most innovative companies on how patent intelligence can be applied to help your legal team make the right decisions for managing patent portfolios.
Reports & Case Studies
The latest research, insights and customer case studies from Clarivate.
Featured reports
China’s research landscape
This new report from ISI charts the exceptional research trajectory that China has followed over the last 40 years.
Enabling a pharmaceutical company to enter new markets with confidence
See how the Clarivate patent search team performed a freedom to operate (FTO) search to help a pharma company enter new markets.
The Clarivate podcast series enables us to address issues in key business areas in new and interesting ways. Listen to our podcasts
Featured podcasts
From lab to life: The transformative power of synthetic biology
Rapid advancements in technology and science are shaping a new era, with AI and synthetic biology, or “syn-bio,” at the forefront. Jim Collins, professor at MIT and a widely recognized trailblazer in syn-bio, helps listeners navigate through its exciting but complex landscape.
Artificial Intelligence: Building bridges between science and policy
Leveraging AI tools for the greater good is the passion that drives Jaron Porciello, guest speaker in the latest episode of our “Ideas to Innovation Season 2″ podcast.
About us
Newsroom
Voice of Customer
Customer Stories
Support
Scientific & Academic Research
Content Solutions
Books & Marketplaces
Library Software
Solutions for Government
Portfolio Strategy & Business Development
Research & Development
Commercialization
Manufacturing
Consulting Services
MedTech
Generics
IP Management Software
Patent Services
Patent Intelligence
Brand IP Solutions
Litigation Intelligence
Blog
Clarivate Innovation Exchange
Researcher Recognition
Podcasts
The Clarivate podcast series enables us to address issues in key business areas in new and interesting ways.
In 2022, sales of branded MAb biologics in oncology exceeded $43 billion in the major pharmaceutical markets (United States, EU5, and Japan), and sales of biosimilars totaled approximately $5.6…
Clarivate Epidemiology’s coverage of BRAF comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France, Germany, Italy,…
Clarivate Epidemiology’s coverage of RAS comprises epidemiological estimates of key patient populations with the biomarker in the major mature pharmaceutical markets (the United States, France,…
Clarivate Epidemiology’s coverage of anaplastic lymphoma kinase (ALK) comprises epidemiological estimates of key patient populations with the biomarker in the major mature pharmaceutical markets…